Behavioral Intervention
Healthy Food Incentives for Type 2 Diabetes
Recruiting1 award4 criteria
Multiple Locations, Alberta
This trial will investigate the reach, effectiveness, adoption, implementation, and maintenance of a healthy food prescription incentive program among adults who are experiencing food insecurity and persistent hyperglycemia.
Competitive Inhibitor
Phosphatidylserine for Type 2 Diabetes
Recruiting0 awards3 criteria
Columbia, Missouri
This trial is testing a dietary supplement called phosphatidylserine to see if it can help improve blood flow in people with Type 2 Diabetes. The supplement works by blocking an enzyme that affects blood vessels. Researchers will compare the effects of the supplement over a period of time.
Behavioral Intervention
Family vs Standard Diabetes Education for Type 2 Diabetes
Recruiting1 award4 criteria
Fayetteville, Arkansas
This trial will compare the effectiveness of a diabetes education program that includes family members to a diabetes education program that does not include family members.
Popular Filters
Trials for Type 2 Diabetes Patients
N/A
Dietary Interventions for Diabetes Prevention
Recruiting1 award2 criteria
Stanford, California
This trial aims to prevent diabetes by creating personalized diet plans based on individual differences in how people develop the disease. It focuses on people with pre-diabetes or diabetes and uses biomarkers to diagnose and tailor diets early.
Continuous Glucose Monitoring for Diabetes
Recruiting0 awards1 criteria
Baltimore, Maryland
This trial is testing a new system called the Glucose Telemetry System (GTS) that sends blood sugar levels from a patient's bedside to a monitor at the nurse's station. It aims to help hospitalized Veterans with diabetes by preventing dangerously low blood sugar levels. The system allows nurses to keep track of patients' blood sugar without entering the room often. A new system has been developed to monitor blood sugar levels in diabetic patients.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
Recruiting1 award4 criteria
Fort Worth, Texas
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
Trials for T2D Patients
N/A
Dietary Interventions for Diabetes Prevention
Recruiting1 award2 criteria
Stanford, California
This trial aims to prevent diabetes by creating personalized diet plans based on individual differences in how people develop the disease. It focuses on people with pre-diabetes or diabetes and uses biomarkers to diagnose and tailor diets early.
Continuous Glucose Monitoring for Diabetes
Recruiting0 awards1 criteria
Baltimore, Maryland
This trial is testing a new system called the Glucose Telemetry System (GTS) that sends blood sugar levels from a patient's bedside to a monitor at the nurse's station. It aims to help hospitalized Veterans with diabetes by preventing dangerously low blood sugar levels. The system allows nurses to keep track of patients' blood sugar without entering the room often. A new system has been developed to monitor blood sugar levels in diabetic patients.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
Recruiting1 award4 criteria
Fort Worth, Texas
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
Phase 3 Trials
GLP-1 Receptor Agonist
Oral Semaglutide for Type 2 Diabetes in Youth
Recruiting1 awardPhase 3
Los Angeles, California
This trial is testing a new diabetes medicine called semaglutide. It focuses on children and teenagers with type 2 diabetes to see if the new medicine is safe and effective. Semaglutide helps control blood sugar levels, which is crucial for managing diabetes. It has been shown to improve blood sugar control and promote weight loss in patients with type 2 diabetes.
Insulin
Inhaled Insulin for Diabetes in Children
Recruiting2 awardsPhase 3
Los Angeles, California
This trial tests an inhalable insulin called Afrezza, combined with a long-acting insulin, in children and teenagers with diabetes. Afrezza helps lower blood sugar quickly after eating, and the long-acting insulin keeps it stable all day. The study aims to see if this combination is safe and effective.
GLP-1 Receptor Agonist
Semaglutide + Low-Dose Insulin Glargine for Type 2 Diabetes
Recruiting2 awardsPhase 3
West Des Moines, Iowa
This trial compares semaglutide with insulin glargine in people with type 2 diabetes, looking at how well they control blood sugar levels. Participants will take one medicine or the other for 47 weeks and have 9 clinic visits, 15 phone/video calls, and 1 home visit. They will also wear a sensor measuring blood sugar for 2 periods of 10 days.
Trials With No Placebo
N/A
Dietary Interventions for Diabetes Prevention
Recruiting1 award2 criteria
Stanford, California
This trial aims to prevent diabetes by creating personalized diet plans based on individual differences in how people develop the disease. It focuses on people with pre-diabetes or diabetes and uses biomarkers to diagnose and tailor diets early.
Behavioural Intervention
Medication Optimization Intervention for HIV/AIDS
Recruiting1 award4 criteria
Fort Worth, Texas
This trial will compare the health outcomes of two groups of African-Americans with HIV who either receive medication optimization with access to their medical records or usual care without access to records.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.